Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemical Agents for Microbial Control01:27

Chemical Agents for Microbial Control

198
Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
198

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The complete chloroplast genome and phylogenetic analysis of <i>Viburnum furcatum</i> (adoxaceae).

Mitochondrial DNA. Part B, Resources·2026
Same author

Solvent-modulated co-assembly of short-chain glucan and Kraft lignin into multifunctional nanoparticles for photostable UV protection.

International journal of biological macromolecules·2026
Same author

Fatty acid-incorporated resistant starch nanoparticles for enhanced rheology and syneresis control in set-style yogurt.

Food chemistry·2026
Same author

Selective magnetic extraction of calcium-based food additives using polystyrene sulfonate-functionalized starch magnetic particles.

Food chemistry·2026
Same author

Corrigendum to "Starch nanoparticle platform for oral delivery of sinigrin in colitis therapy" [Carbohydrate Polymers 367 (2025) 124032].

Carbohydrate polymers·2026
Same author

Presidential address 2026: celebrating academic excellence and expanding computer-based testing across health professions.

Journal of educational evaluation for health professions·2026
Same journal

Botryolides F and G from the Fungus <i>Bartalinia robillardoides</i> with Anthelmintic Activity.

Journal of natural products·2026
Same journal

Characterization of Cyclotides via LC-MS/MS from the Vietnamese Plant <i>Viola annamensis</i> Bak.f.: Insights into Antimicrobial and Larvicidal Activities.

Journal of natural products·2026
Same journal

Correction to "Structure and Absolute Configuration of Diterpenoids from <i>Hymenaea stigonocarpa</i>".

Journal of natural products·2026
Same journal

Goyangamins A-C, Three Pairs of Enantiomeric 2(1<i>H</i>)-Quinolinone Alkaloid Dimers with Antisenescent Activity from <i>Tetradium daniellii</i>.

Journal of natural products·2026
Same journal

Polycyclic-Fused Cytochalasins with Anti-Liver Fibrosis Activity Produced by the Endophytic Fungus <i>Trichoderma harzianum</i>.

Journal of natural products·2026
Same journal

Oleraciamides A and B: Confirmation and Revision of Structures.

Journal of natural products·2026
See all related articles

Related Experiment Video

Updated: Sep 5, 2025

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.7K

Micrococcin P2 Targets Clostridioides difficile.

Young-Jin Son1,2, Young-Rok Kim3, Sang-Hun Oh3

  • 1A&J Science Co., Ltd., 80 Chumbok Road, Dong Gu, Daegu, 41061, Republic of Korea.

Journal of Natural Products
|July 11, 2022
PubMed
Summary
This summary is machine-generated.

Micrococcin P2 (MP2) shows potent activity against Clostridioides difficile infections. In vivo studies demonstrate MP2 is superior to vancomycin and fidaxomicin, highlighting its potential as a novel antibiotic platform.

More Related Videos

Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD
13:34

Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD

Published on: December 30, 2016

11.6K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.0K

Related Experiment Videos

Last Updated: Sep 5, 2025

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.7K
Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD
13:34

Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD

Published on: December 30, 2016

11.6K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

39.0K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Clostridioides difficile infection (CDI) presents a significant global health challenge.
  • Existing antibiotic treatments face limitations, necessitating novel therapeutic strategies.
  • Micrococcin P2 (MP2) has emerged as a promising candidate due to its unique properties.

Purpose of the Study:

  • To evaluate the efficacy of micrococcin P2 (MP2) as an anti-Clostridioides difficile agent.
  • To compare the effectiveness of MP2 against vancomycin and fidaxomicin.
  • To assess the potential of MP2 as a platform for developing new CDI therapeutics.

Main Methods:

  • In vitro assays using clinical isolates of Clostridioides difficile.
  • Time-kill kinetic studies utilizing hypervirulent C. difficile ribotype 027.
  • In vivo efficacy assessment in dextran sulfate sodium (DSS)-induced mouse models of CDI.

Main Results:

  • Extensive in vitro studies identified MP2 as a highly effective anti-C. difficile compound.
  • MP2 demonstrated a distinct mode of action and favorable pharmacokinetic properties.
  • In vivo studies showed MP2 outperformed vancomycin and fidaxomicin against C. difficile ribotype 027.

Conclusions:

  • Micrococcin P2 exhibits significant therapeutic potential for treating Clostridioides difficile infections.
  • MP2's unique mechanism and superior in vivo efficacy position it as a valuable lead compound.
  • Further development of MP2 is warranted for novel antibiotic discovery against CDI.